Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment

Sleep Medicine Reviews - Tập 42 - Trang 211-219 - 2018
Jordan Gaines1, Alexandros N. Vgontzas1, Julio Fernandez-Mendoza1, Edward O. Bixler1
1Sleep Research and Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, PA, USA

Tài liệu tham khảo

Leger, 2012, Impact of sleep apnea on economics, Sleep Med Rev, 16, 455, 10.1016/j.smrv.2011.10.001 Young, 1993, The occurrence of sleep-disordered breathing among middle-aged adults, N Engl J Med, 328, 1230, 10.1056/NEJM199304293281704 Bixler, 1998, Effects of age on sleep apnea in men: I. Prevalence and severity, Am J Respir Crit Care Med, 157, 144, 10.1164/ajrccm.157.1.9706079 Bixler, 2001, Prevalence of sleep-disordered breathing in women: effects of gender, Am J Respir Crit Care Med, 163, 608, 10.1164/ajrccm.163.3.9911064 Peppard, 2013, Increased prevalence of sleep-disordered breathing in adults, Am J Epidemiol, 177, 1006, 10.1093/aje/kws342 Ford, 2005, Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence, Diabetes Care, 28, 1769, 10.2337/diacare.28.7.1769 Ford, 2005, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S, Diabetes Care, 28, 2745, 10.2337/diacare.28.11.2745 Vgontzas, 2005, Sleep apnea is a manifestation of the metabolic syndrome, Sleep Med Rev, 9, 211, 10.1016/j.smrv.2005.01.006 Coughlin, 2004, Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome, Eur Heart J, 25, 735, 10.1016/j.ehj.2004.02.021 Gruber, 2006, Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state, Cardiovasc Diabetol, 5, 22, 10.1186/1475-2840-5-22 Ford, 2002, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356 Bixler, 2000, Association of hypertension and sleep-disordered breathing, Arch Intern Med, 160, 2289, 10.1001/archinte.160.15.2289 Sjöström, 2002, Prevalence of sleep apnoea and snoring in hypertensive men: a population based study, Thorax, 57, 602, 10.1136/thorax.57.7.602 Lavie, 2009, Unexpected survival advantage in elderly people with moderate sleep apnoea, J Sleep Res, 18, 397, 10.1111/j.1365-2869.2009.00754.x Gottlieb, 2010, Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health Study, Circulation, 122, 352, 10.1161/CIRCULATIONAHA.109.901801 Bixler, 2005, Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression, J Clin Endocrinol Metab, 90, 4510, 10.1210/jc.2005-0035 Vgontzas, 2008, Excessive daytime sleepiness in sleep apnea: it is not just apnea hypopnea index, Sleep Med, 9, 712, 10.1016/j.sleep.2008.05.001 Peppard, 2000, Longitudinal study of moderate weight change and sleep-disordered breathing, JAMA, 284, 3015, 10.1001/jama.284.23.3015 Huang, 2009, A comprehensive definition for metabolic syndrome, Dis Model Mech, 2, 231, 10.1242/dmm.001180 Vgontzas, 2000, Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia, J Clin Endocrinol Metab, 85, 1151, 10.1210/jcem.85.3.6484 Kritikou, 2013, Sleep apnoea and visceral adiposity in middle-aged male and female subjects, Eur Respir J, 41, 601, 10.1183/09031936.00183411 Kritikou, 2014, Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females, Eur Respir J, 43, 145, 10.1183/09031936.00126712 Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/edrv.21.6.0415 Bixler, 2016, Natural history of sleep disordered breathing in prepubertal children transitioning to adolescence, Eur Respir J, 47, 1402, 10.1183/13993003.01771-2015 Gaines, 2017, Increased inflammation from childhood to adolescence predicts sleep apnea in boys: a preliminary study, Brain Behav Immun, 64, 259, 10.1016/j.bbi.2017.04.011 Lubrano, 2012, Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome, PLoS One, 7, e47059, 10.1371/journal.pone.0047059 Deegan, 1995, Pathophysiology of obstructive sleep apnoea, Eur Respir J, 8, 1161, 10.1183/09031936.95.08071161 Gueugneau, 2015, Skeletal muscle lipid content and oxidative activity in relation to muscle fiber type in aging and metabolic syndrome, J Gerontol A Biol Sci Med Sci, 70, 566, 10.1093/gerona/glu086 Poelkens, 2013, Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome, Exp Physiol, 98, 1485, 10.1113/expphysiol.2013.072710 Yokoe, 2003, Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure, Circulation, 107, 1129, 10.1161/01.CIR.0000052627.99976.18 Shamsuzzaman, 2002, Elevated C-reactive protein in patients with obstructive sleep apnea, Circulation, 105, 2462, 10.1161/01.CIR.0000018948.95175.03 Chien, 2012, C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea, Sleep Breath, 16, 629, 10.1007/s11325-011-0549-2 Tauman, 2004, Plasma C-reactive protein levels among children with sleep-disordered breathing, Pediatrics, 113, e564, 10.1542/peds.113.6.e564 Larkin, 2005, Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration, Circulation, 111, 1978, 10.1161/01.CIR.0000161819.76138.5E Rubinstein, 1995, Nasal inflammation in patients with obstructive sleep apnea, Laryngoscope, 105, 175, 10.1288/00005537-199502000-00012 Sekosan, 1996, Inflammation in the uvula mucosa of patients with obstructive sleep apnea, Laryngoscope, 106, 1018, 10.1097/00005537-199608000-00021 Olopade, 1997, Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea, Chest, 111, 1500, 10.1378/chest.111.6.1500 Goldbart, 2006, Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome, Chest, 130, 143, 10.1378/chest.130.1.143 Sériès, 2004, Influence of weight and sleep apnea status on immunologic and structural features of the uvula, Am J Respir Crit Care Med, 170, 1114, 10.1164/rccm.200404-458OC Ryan, 2005, Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome, Circulation, 112, 2660, 10.1161/CIRCULATIONAHA.105.556746 Schipper, 2012, Adipose tissue-resident immune cells: key players in immunometabolism, Trends Endocrinol Metab, 23, 407, 10.1016/j.tem.2012.05.011 Ibrahim, 2010, Subcutaneous and visceral adipose tissue: structural and functional differences, Obes Rev, 11, 11, 10.1111/j.1467-789X.2009.00623.x Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 112, 1785, 10.1172/JCI20514 Gaines, 2016, Inflammation mediates the association between visceral adiposity and obstructive sleep apnea in adolescents, Am J Physiol Endocrinol Metab, 311, E851, 10.1152/ajpendo.00249.2016 Hibbs, 2008, Prenatal and neonatal risk factors for sleep disorder breathing in school-aged children born preterm, J Pediatr, 153, 176, 10.1016/j.jpeds.2008.01.040 Calhoun, 2010, Prenatal and perinatal complications: is it the link between race and SES and childhood sleep disordered breathing?, J Clin Sleep Med, 6, 264, 10.5664/jcsm.27824 Tapia, 2016, Prenatal risk factors associated with the obstructive sleep apnea syndrome in school-aged children born preterm, Sleep, 39, 737, 10.5665/sleep.5618 Rebuffé-Scrive, 1985, Glucocorticoid hormone binding to human adipose tissue, Eur J Clin Invest, 15, 267, 10.1111/j.1365-2362.1985.tb00182.x Arner, 1990, Beta-adrenoceptor expression in human fat cells from different regions, J Clin Invest, 86, 1595, 10.1172/JCI114880 Mårin, 1992, The morphology and metabolism of intraabdominal adipose tissue in men, Metabolism, 41, 1242, 10.1016/0026-0495(92)90016-4 Dobbelsteyn, 2001, A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys, Int J Obes Relat Metab Disord, 25, 652, 10.1038/sj.ijo.0801582 Kuk, 2006, Visceral fat is an independent predictor of all-cause mortality in men, Obesity (Silver Spring), 14, 336, 10.1038/oby.2006.43 Hotamisligil, 1994, Tumor necrosis factor alpha: a key component of the obesity-diabetes link, Diabetes, 43, 1271, 10.2337/diab.43.11.1271 Kern, 2001, Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance, Am J Physiol Endocrinol Metab, 280, E745, 10.1152/ajpendo.2001.280.5.E745 Punjabi, 2002, Sleep-disordered breathing and insulin resistance in middle-aged and overweight men, Am J Respir Crit Care Med, 165, 677, 10.1164/ajrccm.165.5.2104087 Punjabi, 2004, Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study, Am J Epidemiol, 160, 521, 10.1093/aje/kwh261 Ip, 2002, Obstructive sleep apnea is independently associated with insulin resistance, Am J Respir Crit Care Med, 165, 670, 10.1164/ajrccm.165.5.2103001 Polak, 2013, Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure, Sleep, 36, 1483, 10.5665/sleep.3040 Chopra, 2017, Obstructive sleep apnea dynamically increases nocturnal plasma free fatty acids, glucose, and cortisol during sleep, J Clin Endocrinol Metab, 102, 3172, 10.1210/jc.2017-00619 Polotsky, 2009, Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity, Am J Respir Crit Care Med, 179, 228, 10.1164/rccm.200804-608OC Aronsohn, 2010, Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes, Am J Respir Crit Care Med, 181, 507, 10.1164/rccm.200909-1423OC Reichmuth, 2005, Association of sleep apnea and type II diabetes: a population-based study, Am J Respir Crit Care Med, 172, 1590, 10.1164/rccm.200504-637OC Balkau, 2010, High baseline insulin levels associated with 6-year incident observed sleep apnea, Diabetes Care, 33, 1044, 10.2337/dc09-1901 Vgontzas, 2001, Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance, J Clin Endocrinol Metab, 86, 517 Fogel, 2001, Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, 86, 1175 Gopal, 2002, The role of obesity in the increased prevalence of obstructive sleep apnea in patients with polycystic ovarian syndrome, Sleep Med, 3, 401, 10.1016/S1389-9457(02)00033-3 Tasali, 2006, Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 36, 10.1210/jc.2005-1084 Mokhlesi, 2012, Risk of obstructive sleep apnea in obese and non-obese women with polycystic ovary syndrome and healthy reproductively normal women, Fertil Steril, 97, 786, 10.1016/j.fertnstert.2011.12.024 Tsaoussoglou, 2010, Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities, J Clin Endocrinol Metab, 95, 143, 10.1210/jc.2009-0435 Farr, 2017, Current child, but not maternal, snoring is bi-directionally related to adiposity and cardiometabolic risk markers: a cross-sectional and a prospective cohort analysis, Metabolism, 30180 Ha, 2014, Comparison of positional therapy versus continuous positive airway pressure in patients with positional obstructive sleep apnea: a meta-analysis of randomized trials, Sleep Med Rev, 18, 19, 10.1016/j.smrv.2013.05.003 Jullian-Desayes, 2015, Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials, Sleep Med Rev, 21, 23, 10.1016/j.smrv.2014.07.004 Vgontzas, 2008, Selective effects of CPAP on sleep apnoea-associated manifestations, Eur J Clin Invest, 38, 585, 10.1111/j.1365-2362.2008.01984.x Arias, 2008, CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea, Eur Respir J, 32, 1009, 10.1183/09031936.00007008 Kohler, 2009, Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial, Thorax, 64, 67, 10.1136/thx.2008.097931 Hoyos, 2012, Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study, Thorax, 67, 1081, 10.1136/thoraxjnl-2011-201420 Hoyos, 2013, Effect of CPAP on the metabolic syndrome: a randomised sham-controlled study, Thorax, 68, 588, 10.1136/thoraxjnl-2012-203074 Shaw, 2016, The effect of treatment of obstructive sleep apnea on glycemic control in Type 2 diabetes, Am J Respir Crit Care Med, 194, 486, 10.1164/rccm.201511-2260OC Thunström, 2017, CPAP does not reduce inflammatory biomarkers in patients with coronary artery disease and nonsleepy obstructive sleep apnea: a randomized controlled trial, Sleep, 40, 10.1093/sleep/zsx157 Chirinos, 2014, CPAP, weight loss, or both for obstructive sleep apnea, N Engl J Med, 370, 2265, 10.1056/NEJMoa1306187 Kritikou, 2016, Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: effects of continuous positive airway pressure, Eur Respir J, 47, 531, 10.1183/13993003.00319-2015 Vgontzas, 2007, Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy, J Clin Endocrinol Metab, 92, 4199, 10.1210/jc.2007-0774 Schmoller, 2009, Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleep apnea, Metabolism, 58, 848, 10.1016/j.metabol.2009.02.014 Dimsdale, 2000, Effect of continuous positive airway pressure on blood pressure: a placebo trial, Hypertension, 35, 144, 10.1161/01.HYP.35.1.144 Enoz, 2006, UPPP failure due to lingual tonsils and epiglottal laxity, Sleep Med, 7, 660, 10.1016/j.sleep.2006.05.015 Riley, 1993, Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients, Otolaryngol Head Neck Surg, 108, 117, 10.1177/019459989310800203 Vgontzas, 2004, Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist, J Clin Endocrinol Metab, 89, 4409, 10.1210/jc.2003-031929 Brouillette, 2001, Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea, J Pediatr, 138, 838, 10.1067/mpd.2001.114474 Goldbart, 2005, Leukotriene modifier therapy for mild sleep-disordered breathing in children, Am J Respir Crit Care Med, 172, 364, 10.1164/rccm.200408-1064OC Kheirandish-Gozal, 2008, Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome, Pediatrics, 122, e149, 10.1542/peds.2007-3398 Kuhle, 2011, Anti-inflammatory medications for obstructive sleep apnea in children, Cochrane Database Syst Rev, 19, CD007074 Kheirandish-Gozal, 2014, Antiinflammatory therapy outcomes for mild OSA in children, Chest, 146, 88, 10.1378/chest.13-2288 Reading, 2009, Do rheumatoid arthritis patients have a higher risk for sleep apnea?, J Rheumatol, 36, 1869, 10.3899/jrheum.081335 Taylor-Gjevre, 2013, Obstructive sleep apnoea in relation to rheumatic disease, Rheumatology (Oxford), 52, 15, 10.1093/rheumatology/kes210 Walsh, 2012, Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors, J Clin Sleep Med, 8, 643, 10.5664/jcsm.2254 Vgontzas, 2016, Mild-to-moderate obstructive sleep apnea is associated with incident hypertension: a longitudinal, population-based study, Sleep, 40, A158, 10.1093/sleepj/zsx050.425 Kirkness, 2008, Contribution of male sex, age, and obesity to mechanical instability of the upper airway during sleep, J Appl Physiol, 104, 1618, 10.1152/japplphysiol.00045.2008 Edwards, 2014, Obstructive sleep apnea in older adults is a distinctly different physiological phenotype, Sleep, 37, 1227, 10.5665/sleep.3844 Saint Martin, 2015, Association of body fat composition and obstructive sleep apnea in the elderly: a longitudinal study, Obesity, 23, 1511, 10.1002/oby.21121 Wolkove, 2008, Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea, Cancer Respir J, 15, 365 Wozniak DR, Lasserson TJ, Smith I. Education, supportive and behavioural intervensions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnea. Cochrane Database Syst Rev 1:CD007736. McArdle N, Kingshott R, Engleman HM, Mackay TW, Douglas NJ. Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax 56: 513-518. Mullington, 2016, Developing biomarker arrays predicting sleep and circadian-coupled risks to health, Sleep, 39, 727, 10.5665/sleep.5616 Mehra, 2017, Building evidence implicating novel cardiovascular biomarkers in obstructive sleep apnea, J Clin Sleep Med, 13, 361, 10.5664/jcsm.6476 Gaines, 2015, Gender differences in the association of sleep apnea and inflammation, Brain Behav Immun, 47, 211, 10.1016/j.bbi.2014.11.013 Li, 2017, Objective, but not subjective, sleepiness is associated with inflammation in sleep apnea, Sleep, 40, 10.1093/sleep/zsw033 Nagayoshi, 2016, Obstructive sleep apnea and incident type 2 diabetes, Sleep Med, 25, 156, 10.1016/j.sleep.2016.05.009 Gaines, 2017, C-reactive protein improves the ability to detect cardiometabolic risk in mild-to-moderate obstructive sleep apnea, Physiol Rep, 5, e13454, 10.14814/phy2.13454 Fleming, 2016, Blood biomarkers of endocrine, immune, inflammatory, and metabolic systems in obstructive sleep apnea, Clin Biochem, 49, 854, 10.1016/j.clinbiochem.2016.05.005